1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
- 2017
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Prognostic role of the tumour microenvironment in esophago-gastric, pancreatic and periampullary adenocarcinoma: B cells and beyond
2017)(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Predictive factors in pancreatic ductal adenocarcinoma: Role of the inflammatory response.
(
- Contribution to journal › Article